Industry Active Role In Guidance Development Urged By Wyeth's Burlington
Executive Summary
Regulated industry should take a more aggressive approach to writing guidances, Wyeth-Ayerst Senior VP-Global Regulatory Affairs Bruce Burlington, PhD, told a Parenteral Drugs Association/FDA joint conference Sept. 29 in Bethesda, Md.